512 related articles for article (PubMed ID: 34179737)
21. Associations between predicted vitamin D status, vitamin D intake, and risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) severity.
Ma W; Nguyen LH; Yue Y; Ding M; Drew DA; Wang K; Merino J; Rich-Edwards JW; Sun Q; Camargo CA; Giovannucci E; Willett W; Manson JE; Song M; Bhupathiraju SN; Chan AT
Am J Clin Nutr; 2022 Apr; 115(4):1123-1133. PubMed ID: 34864844
[TBL] [Abstract][Full Text] [Related]
22. The correlation between serum 25-hydroxy-vitamin D levels and anti-SARS-CoV-2 S-RBD IgG and neutralizing antibody levels among cancer patients receiving COVID-19 vaccines.
Rachman A; Iriani A; Priantono D; Rumondor BB; Betsy R; Juanputra S
Front Nutr; 2022; 9():1066411. PubMed ID: 36583218
[TBL] [Abstract][Full Text] [Related]
23. Influence of vitamin D status on hospital length of stay and prognosis in hospitalized patients with moderate to severe COVID-19: a multicenter prospective cohort study.
Reis BZ; Fernandes AL; Sales LP; Santos MD; Dos Santos CC; Pinto AJ; Goessler KF; Franco AS; Duran CSC; Silva CBR; Macêdo MB; Dalmolin HHH; Baggio J; Balbi GGM; Antonangelo L; Caparbo VF; Gualano B; Murai IH; Pereira RMR
Am J Clin Nutr; 2021 Aug; 114(2):598-604. PubMed ID: 34020451
[TBL] [Abstract][Full Text] [Related]
24. High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study.
Ling SF; Broad E; Murphy R; Pappachan JM; Pardesi-Newton S; Kong MF; Jude EB
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33322317
[TBL] [Abstract][Full Text] [Related]
25. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
26. Correlation of Plasma 25(OH)D
Alabdullatif W; Almnaizel A; Alhijji A; Alshathri A; Albarrag A; Bindayel I
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111039
[TBL] [Abstract][Full Text] [Related]
27. Serum vitamin D levels and COVID-19 during pregnancy: A systematic review and meta-analysis.
Mazaheri-Tehrani S; Mirzapour MH; Yazdi M; Fakhrolmobasheri M; Abhari AP
Clin Nutr ESPEN; 2022 Oct; 51():120-127. PubMed ID: 36184196
[TBL] [Abstract][Full Text] [Related]
28. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
29. Association between vitamin D supplementation or serum vitamin D level and susceptibility to SARS-CoV-2 infection or COVID-19 including clinical course, morbidity and mortality outcomes? A systematic review.
Grove A; Osokogu O; Al-Khudairy L; Mehrabian A; Zanganeh M; Brown A; Court R; Taylor-Phillips S; Uthman OA; McCarthy N; Kumar S; Clarke A
BMJ Open; 2021 May; 11(5):e043737. PubMed ID: 34049903
[TBL] [Abstract][Full Text] [Related]
30. Correlation between 25-hydroxyvitamin D/D3 Deficiency and COVID-19 Disease Severity in Adults from Northern Colorado.
Baxter BA; Ryan MG; LaVergne SM; Stromberg S; Berry K; Tipton M; Natter N; Nudell N; McFann K; Dunn J; Webb TL; Armstrong M; Reisdorph N; Ryan EP
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558362
[TBL] [Abstract][Full Text] [Related]
31. The relationship between 25(OH) vitamin D levels and COVID-19 onset and disease course in Spanish patients.
Diaz-Curiel M; Cabello A; Arboiro-Pinel R; Mansur JL; Heili-Frades S; Mahillo-Fernandez I; Herrero-González A; Andrade-Poveda M
J Steroid Biochem Mol Biol; 2021 Sep; 212():105928. PubMed ID: 34091026
[TBL] [Abstract][Full Text] [Related]
32. The link between COVID-19 and VItamin D (VIVID): A systematic review and meta-analysis.
Bassatne A; Basbous M; Chakhtoura M; El Zein O; Rahme M; El-Hajj Fuleihan G
Metabolism; 2021 Jun; 119():154753. PubMed ID: 33774074
[TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 infection during pregnancy and risk of preeclampsia: a systematic review and meta-analysis.
Conde-Agudelo A; Romero R
Am J Obstet Gynecol; 2022 Jan; 226(1):68-89.e3. PubMed ID: 34302772
[TBL] [Abstract][Full Text] [Related]
34. Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness.
Dror AA; Morozov N; Daoud A; Namir Y; Yakir O; Shachar Y; Lifshitz M; Segal E; Fisher L; Mizrachi M; Eisenbach N; Rayan D; Gruber M; Bashkin A; Kaykov E; Barhoum M; Edelstein M; Sela E
PLoS One; 2022; 17(2):e0263069. PubMed ID: 35113901
[TBL] [Abstract][Full Text] [Related]
35. Association of Serum Vitamin D level and COVID-19 infection: A Case-control Study.
Abdrabbo AlYafei N; Fathima Jaleel BN; Abdel-Salam AG; Ali Al-Saadi H; Al Abdulla SA
Qatar Med J; 2022; 2022(4):48. PubMed ID: 36504923
[TBL] [Abstract][Full Text] [Related]
36. Impact of Age and Clinico-Biochemical Parameters on Clinical Severity of SARS-CoV-2 Infection.
Wani SA; Gulzar B; Khan MS; Majid S; Bhat IA
Intervirology; 2023; 66(1):88-96. PubMed ID: 37263256
[TBL] [Abstract][Full Text] [Related]
37. Vitamin D in SARS-CoV-2 infection.
Decyk A; Kobylińska M; Antosik K; Kurowska K
Rocz Panstw Zakl Hig; 2022; 73(1):5-12. PubMed ID: 35322953
[TBL] [Abstract][Full Text] [Related]
38. Strong Association between Vitamin D Receptor Gene and Severe Acute Respiratory Syndrome coronavirus 2 Infectious Variants.
Mamurova B; Akan G; Mogol E; Turgay A; Tuncel G; Evren EU; Evren H; Suer K; Sanlidag T; Ergoren MC
Glob Med Genet; 2023 Jan; 10(1):27-33. PubMed ID: 36819669
[TBL] [Abstract][Full Text] [Related]
39. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
[TBL] [Abstract][Full Text] [Related]
40. Low 25(OH)D Level Is Associated with Severe Course and Poor Prognosis in COVID-19.
Karonova TL; Andreeva AT; Golovatuk KA; Bykova ES; Simanenkova AV; Vashukova MA; Grant WB; Shlyakhto EV
Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
